(Q37477414)

20 August 2017

1 reference

title

From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour (English)

1 reference

20 August 2017

0 references

2

Edward T Bullmore

0 references

author name string

Pradeep J Nathan

series ordinal

1

1 reference

20 August 2017

publication date

12 May 2009

1 reference

The International Journal of Neuropsychopharmacology

20 August 2017

published in

1 reference

20 August 2017

volume

12

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

995-1008

1 reference

Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Why do we eat? A neural systems approach

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Flavor enhances the antidipsogenic effect of naloxone.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Sugars and fats: the neurobiology of preference

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Changes of beta-endorphin and somatostatin concentrations in different hypothalamic areas of female rats after chronic starvation

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eating.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Targeting opioid receptor heterodimers: strategies for screening and drug development

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Prevalence and correlates of binge eating disorder in a community sample

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Feared food in dieting and non-dieting young women: a preliminary validation of the Food Phobia Survey

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effect of orlistat in obese patients with binge eating disorder

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naloxone's effect on meal microstructure of sucrose and cornstarch diets

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Potency of naloxone's anorectic effect in rats is dependent on diet preference.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naloxone's anorectic effect is dependent upon the relative palatability of food

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Acquisition of a palatable-food-sustained appetitive behavior in satiated rats is dependent on the dopaminergic response to this food in limbic areas.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

How visual images of chocolate affect the craving and guilt of female dieters

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement☆

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Binge eating in the obese

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Relationship between plasma concentrations of immunoreactive beta-endorphin and food intake in rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Bingeing rats: a model of intermittent excessive behavior?

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naloxone: effects on food and water consumption in the non-deprived and deprived rat.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naloxone effects on sucrose-motivated behavior.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Chronic administration of nalmefene leads to increased food intake and body weight gain in mice

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Basal and morphine‐evoked dopaminergic neurotransmission in the nucleus accumbens of MOR‐ and DOR‐knockout mice

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Food reward: brain substrates of wanting and liking

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Nucleus accumbens opioid, GABAergic, and dopaminergic modulation of palatable food motivation: Contrasting effects revealed by a progressive ratio study in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The mu-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Food deprivation increases the mRNA expression of micro-opioid receptors in the ventral medial hypothalamus and arcuate nucleus

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Lower pleasantness of palatable foods in nalmefene-treated human volunteers.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Increased expression of mu opioid receptors in animals susceptible to diet-induced obesity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid peptides and the control of human ingestive behaviour

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Differential regulation of the consummatory, motivational and anticipatory aspects of feeding behavior by dopaminergic and opioidergic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Selective effects of naltrexone on food pleasantness and intake.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The amygdala is critical for opioid-mediated binge eating of fat.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Examining the addictive-like properties of binge eating using an animal model of sugar dependence

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of long-term therapy with naltrexone on body weight in obesity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effect of exposure to a forbidden food on eating in restrained and unrestrained women

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A sucrose-based maintenance diet increases sensitivity to appetite suppressant effects of naloxone.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naloxone's effects on operant responding depend upon level of deprivation.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Endogenous opioid peptides and regulation of drinking and feeding

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Review and meta-analysis of pharmacotherapy for binge-eating disorder

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Chronic blockade of opiate receptors: Influence on reproduction and body weight in female rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opiate Receptor: Demonstration in Nervous Tissue

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Decreased motivation to eat in mu-opioid receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The effect of naltrexone on taste detection and recognition threshold.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

https://api.crossref.org/works/10.1017%2FS146114570900039X

1 reference

7 January 2021

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid receptor modulation of feeding-evoked dopamine release in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene".

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

d-fenfluramine treatment of binge eating disorder

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Eating patterns and obesity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The epidemiology of obesity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Stress-Induced Eating Is Mediated Through Endogenous Opiates

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

From motivation to action: functional interface between the limbic system and the motor system.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

High-dose naltrexone therapy and dietary counseling for obesity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Effects of Sibutramine on Binge Eating, Hunger, and Fullness in a Laboratory Human Feeding Paradigm

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Potentiation of regulatory volume decrease by P2U purinoceptors in HSG-PA cells

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The neuroscience of natural rewards: relevance to addictive drugs.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal, and food reward

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid modulation of taste hedonics within the ventral striatum.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Functional specificity of ventral striatal compartments in appetitive behaviors

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Mu-opioid receptor knockout mice show diminished food-anticipatory activity

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Everyday dietary behaviour and the relationship between attention and meal size

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Neurotransmitter regulation of dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Macronutrient analysis of binge eating in bulimia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

G-protein-coupled receptor heterodimerization modulates receptor function

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naltrexone reverses bulimic symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Conditioned place preferences (CPPs) to high-caloric "snack foods" in rat strains genetically prone vs. resistant to diet-induced obesity: resistance to naltrexone blockade.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Reduction of anxiety after restricted feeding in the rat: implication for eating disorders

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Modifications of nutrient selection induced by naloxone in rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Stimulation of food intake following opioid microinjection into the nucleus accumbens septi in rats

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Brain and peripheral opioid peptides after changes in ingestive behavior

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Central opioids and consumption of sweet tastants: when reward outweighs homeostasis.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

The role of dieting in binge eating disorder: etiology and treatment implications

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Suppression of appetitive behavior in the rat by naloxone: Lack of effect of prior morphine dependence

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Failure of naltrexone to affect the pleasantness or intake of food.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Opioid reward mechanisms: a key role in drug abuse?

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Differential involvement of endogenous opioids in sucrose consumption and food reinforcement

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Selective reward deficit in mice lacking beta-endorphin and enkephalin.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Increases in food intake or food-seeking behavior induced by GABAergic, opioid, or dopaminergic stimulation of the nucleus accumbens: is it hunger?

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

A new animal model of binge eating: key synergistic role of past caloric restriction and stress.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

Restrained eating: an experimental disentanglement of the disinhibiting variables of perceived calories and food type

1 reference

https://api.crossref.org/works/10.1017%2FS146114570900039X

7 January 2021

10.1017/S146114570900039X

Identifiers

DOI

1 reference

release_vc3wp2wxwnhfpl2ovnwovgspty

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vc3wp2wxwnhfpl2ovnwovgspty

24 November 2022

mapped directly with Wikidata item

1 reference